Next-gen obesity biotech Metsera has filed to debut on the public markets, proposing an IPO nine months after emerging. | ...

Metsera has filed for an initial public offering. The clinical-stage biopharmaceutical company submitted a registration statement to regulators on Friday, saying it intends to list under the ticker ...

The terms of the IPO were not disclosed in the filing. Strong equity markets, falling interest rates and hopes of a ...

The stock's fall snapped a two-day winning streak.

Discover why Arch Capital Group Ltd.'s recent share price weakness presents a buying opportunity with strong fundamentals.

It certainly was a big week — with companies having to raise more than $100 million to make the list. Biotech- and healthcare ...